CRL

Charles River Laboratories International, Inc. · Healthcare · Medical - Diagnostics & Research
$231.21
+1.46 (+0.64%)
Mkt Cap: 11.14B
Key Metrics
MetricValue
P/E RatioN/A
EV/EBITDAN/A
ROEN/A
Gross MarginN/A
Revenue GrowthN/A
FCF Yield5.1%
Dividend YieldN/A
Market Cap11.14B
Volume964.8K
Recent News
Will Charles River (CRL) Beat Estimates Again in Its Next Earnings Report?
zacks.com · 2026-07-14
Charles River Provides NGS Services to Arovella Therapeutics, Accelerating Progress Toward Alternative Cancer Treatment Approaches
gurufocus.com · 2026-07-13
Charles River Provides NGS Services to Arovella Therapeutics, Accelerating Progress Toward Alternative Cancer Treatment Approaches
businesswire.com · 2026-07-13
Achieve Life Sciences: Despite CRL, A Success Is Achieve-Able
seekingalpha.com · 2026-07-07
Did Charles River Laboratories International, Inc. Insiders Breach their Fiduciary Duties to Shareholders?
prnewswire.com · 2026-07-03
LH or CRL: Which Is the Better Value Stock Right Now?
zacks.com · 2026-07-01

Unlock the Full Deep Scan

9 AI agents analyze CRL across earnings, insider flow, macro conditions, corporate strategy, market microstructure, and price action.

Sign Up Free →